Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Shu-ling Rong"'
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-14 (2019)
Abstract Background The clinical significance of stem cell therapy in the treatment of dilated cardiomyopathy remains unclear. This systemic appraisal and meta-analysis aimed to assess the efficacy and safety of stem cell therapy in patients with dil
Externí odkaz:
https://doaj.org/article/49536e40792740f9826132ac9721477d
Autor:
Shu-Ling Rong, Xiao-Lin Wang, Cui-Ying Zhang, Zhuo-Hui Song, Lu-Hua Cui, Xiao-Feng He, Xu-Jiong Li, Hui-Jin Du, Bao Li
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0196413 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0175807.].
Externí odkaz:
https://doaj.org/article/d2df075da2b645368d599f00885f4ac7
Autor:
Shu-Ling Rong, Xiao-Lin Wang, Cui-Ying Zhang, Zhuo-Hui Song, Lu-Hua Cui, Xiao-Feng He, Xu-Jiong Li, Hui-Jin Du, Bao Li
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0175807 (2017)
Skeletal myoblast transplantation seems a promising approach for the repair of myocardial infarction (MI). However, the low engraftment efficacy and impaired angiogenic ability limit the clinical efficiency of the myoblasts. Gene engineering with ang
Externí odkaz:
https://doaj.org/article/3302b563f1544b9981063f78a50c7652
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-14 (2019)
Journal of Translational Medicine
Journal of Translational Medicine
Background The clinical significance of stem cell therapy in the treatment of dilated cardiomyopathy remains unclear. This systemic appraisal and meta-analysis aimed to assess the efficacy and safety of stem cell therapy in patients with dilated card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e7e527fa2b4245d730f1ccac1adf85
http://link.springer.com/article/10.1186/s12967-019-1966-4
http://link.springer.com/article/10.1186/s12967-019-1966-4
Autor:
Yong-Jin Wang, Yan-zhang Gao, Yong-xin Lu, Yu-qin Wang, Shu-ling Rong, Shao-hua Mi, Yuhua Liao, Xiao-lin Wang, Qi-Yun Liu, Chao Chang
Publikováno v:
Chinese Medical Journal. 121:347-354
BACKGROUND Cell transplantation for myocardial repair is limited by early cell death. Gene therapy with human growth hormone (hGH) has been shown to promote angiogenesis and attenuate apoptosis in the experimental animal. This study was conducted to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62ace6c68c6424f59dc9117dde74e14d
https://doi.org/10.1097/00029330-200802020-00013
https://doi.org/10.1097/00029330-200802020-00013
Autor:
Hui-Jin Du, Bao Li, Lu-Hua Cui, Zhuo-Hui Song, Cui-Ying Zhang, Shu-Ling Rong, Xu-Jiong Li, Xiao-Feng He, Xiao-Lin Wang
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0175807 (2017)
Background Skeletal myoblast transplantation seems a promising approach for the repair of myocardial infarction (MI). However, the low engraftment efficacy and impaired angiogenic ability limit the clinical efficiency of the myoblasts. Gene engineeri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b62501aca88dd75796bb32e4190422c9
https://doi.org/10.1371/journal.pone.0175807
https://doi.org/10.1371/journal.pone.0175807
Autor:
Shu-Ling, Rong, Yong-Jin, Wang, Xiao-Lin, Wang, Yong-Xin, Lu, Yin, Wu, Qi-Yun, Liu, Shao-Hua, Mi, Yu-Lan, Xu
Publikováno v:
Chinese medical journal. 123(24)
Tissue-engineered bioartificial muscle-based gene therapy represents a promising approach for the treatment of heart diseases. Experimental and clinical studies suggest that systemic administration of insulin-like growth factor-1 (IGF-1) protein or o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27575822b611f912dc3646b370378552
https://pubmed.ncbi.nlm.nih.gov/22166642
https://pubmed.ncbi.nlm.nih.gov/22166642
Publikováno v:
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban. 28(4)
This study examined the change of p16(INK4a) and PCNA protein expression in myocardium after injection of hIGF-1 gene modified skeletal myoblasts into post-infarction rats. HIGF-1 gene modified skeletal myoblasts (hIGF-1-myoblasts) were injected into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d10bacaf4de65c254b71a839dbb6ae0c
https://pubmed.ncbi.nlm.nih.gov/18704299
https://pubmed.ncbi.nlm.nih.gov/18704299
Autor:
Shao-hua Mi, Yong-xin Lu, Jian-ping Wan, Shu-ling Rong, Chao Chang, Xiao-lin Wang, He-ping Guo, Yan-zhang Gao, Yuhua Liao
Publikováno v:
Chinese medical journal. 119(23)
BACKGROUND This study transferred a recombinant gene encoding human insulin like growth factor-1 (hIGF-1) into modified primary skeletal myoblasts with a retroviral vector (pLgXSN) and determined whether the hIGF-1 promoted growth of skeletal muscle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a55946a3a6b4c1f37504236f1dab2f03
https://pubmed.ncbi.nlm.nih.gov/17199944
https://pubmed.ncbi.nlm.nih.gov/17199944
Autor:
Rong, Shu-Ling, Wang, Xiao-Lin, Zhang, Cui-Ying, Song, Zhuo-Hui, Cui, Lu-Hua, He, Xiao-Feng, Li, Xu-Jiong, Du, Hui-Jin, Li, Bao
Publikováno v:
PLoS ONE. 4/19/2018, Vol. 13 Issue 3, p1-5. 5p.